CACNA2D4
protein-codingcalcium voltage-gated channel auxiliary subunit alpha2delta 4, the group of Calcium voltage-gated channel auxiliary alpha2delta subunits
Gene summary
This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~126.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012507
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AD
Disease ID:MONDO:0015993
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0012507
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0700244
Submitter: ClinGen
Variants in *CACNA2D4* were first associated with autosomal recessive inheritance of retinal cone dystrophy (RCD4) in 2006 (Wycisk et al., 17033974). Over eight probands reported four homozygous variants in this gene including one missense variant, and two large deletions covering multiple exons, as well as one stop gained. This gene-disease association is supported by expression throughout the inner nuclear layer of the retina, photoreceptors and retinal periphery in model organism, zebrafish by RNA *in situ* hybridization (Schlegel et al., 31834350). Additional functional studies show alterations in *Cacna2d4* in mice have significantly reduced transcript levels in the retina leading to structural and functional abnormalities of retinal ribbon synapses including substantial loss of photoreceptor activities and photoreceptor cell death (Wycisk et al., 16877424). More evidence is available in the literature, but the maximum score for genetic evidence and experimental evidence (12.0 pts.) has been reached. In summary, *CACNA2D4* is definitively associated with autosomal recessive inheritance of CACNA2D4-related retinopathy, and this has been has been upheld over time. This classification has been approved by the ClinGen Retina GCEP on March 2nd, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0012507
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CACNA2D4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_172364.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 15 | 257 | 3 | 275 | ||
| missense | 608 | 39 | 7 | 654 | ||
| nonsense | 1 | 12 | 18 | 31 | ||
| start loss | 3 | 3 | ||||
| frameshift | 1 | 12 | 15 | 28 | ||
| splice donor/acceptor (+/-2bp) | 12 | 25 | 37 | |||
| Total | 2 | 36 | 684 | 296 | 10 | 1028 |
Highest pathogenic variant AF is 0.0008479325
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_758952.4 | 38 | MANE Select | |
| Ensembl | ENSP00000372169.4 | 38 | MANE Select | |
| Ensembl | ENSP00000403371.2 | 17 | Standard | |
| Ensembl | ENSP00000468167.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oxytocin signaling pathway - Homo sapiens (human)
- Cardiac muscle contraction - Homo sapiens (human)
- Dilated cardiomyopathy (DCM) - Homo sapiens (human)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human)
Biological Process
- regulation of ion transmembrane transport
- detection of light stimulus involved in visual perception
- calcium ion transmembrane transport
Molecular Function
- voltage-gated calcium channel activity
- metal ion binding
Cellular Component
- plasma membrane
- voltage-gated calcium channel complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382722
- Coding exons
- 38
- Length
- 126880
- Individuals with no LoFs
- 124410
- Homozygous LoFs
- 6
- Heterozygous LoFs
- 456
- Defined
- 124872
- p
- 0.00185
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.752 | 628 | 683 | 0.919 | 0.0000416 | 7405 |
| Missense (PolyPhen) | 135 | 151.29 | 0.89235 | 1639 | ||
| Synonymous | 0.407 | 281 | 290 | 0.970 | 0.0000203 | 2154 |
| Loss of Function | 1.47 | 60 | 73.6 | 0.816 | 0.00000391 | 784 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0011 | notable |
| Latino/Admixed American | 0.00090 | 0.00090 | rare |
| Ashkenazi Jewish | 0.015 | 0.015 | notable |
| East Asian | 0.0020 | 0.0020 | notable |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.0016 | 0.0016 | notable |
| South Asian | 0.0012 | 0.0012 | notable |
| Other | 0.0027 | 0.0025 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. {ECO:0000269|PubMed:12181424}.;
- Disease
- DISEASE: Retinal cone dystrophy 4 (RCD4) [MIM:610478]: Characterized by minimal symptoms except for slowly progressive reduction in visual acuity. {ECO:0000269|PubMed:17033974}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- LoFtool
- 0.722
- RVIS EVS
- 0.93
- RVIS percentile EVS
- 89.66
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.202
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |